Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Nov 12, 2024 17:18 Mylan Settles Patent Suit with Novo Nordisk over Generic Ozempic Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement lawsuit ...

Mylan’s EpiPen, which generated sales of $442m in 2023, became part of Pfizer’s spin-off company Viatris in 2020. Pfizer has ...

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic ...

Dr. Jessica Shepherd, chief medical officer of Hers, joins ABC News Live to discuss how to maintain weight loss during the holiday season. Dr. Leana Wen, emergency physician and former Baltimore ...

Medication patches are available in a limited number of dosage strengths. Occasionally, some patients require a different dosage of a medication than the dosages commercially available in patch ...

This advertisement has not loaded yet, but your article continues below. The salmon are quickly returning to spawn in cool creeks that have been cut off to them for generations Researchers at ...

The global short-acting beta-agonists market, crucial medications for treating asthma and COPD, is poised for substantial ...

Am J Health Syst Pharm. 2012;69(2):116-124.